Try our beta test site

Trial of pIL-12 Electroporation Malignant Melanoma (IL-12MEL)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
OncoSec Medical Incorporated
ClinicalTrials.gov Identifier:
NCT01502293
First received: December 21, 2011
Last updated: February 24, 2017
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2017
  Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)